arXiv:2607.25074stat.MEcs.AI2026-07

用谱方法改进合成控制,发现原始匹配仍更稳定。

Spectral Truncation in Synthetic Control

  • 基于时间主成分构建新匹配空间,可灵活调节保留与舍弃方向权重
  • 实证显示截断谱方法在11种场景下均显著劣于调优的原始路径匹配
  • 预处理去除固定效应后,谱方法优势显现,适合关注机制研究者

合成控制(SC)通过加权组合对照单位来拟合处理单位的前期轨迹。本文研究谱合成控制(Spectral SC),即在捐赠者面板的时间主成分坐标系中进行匹配,并提出一种混合估计器,可分别调节保留与丢弃方向的权重,将原始路径匹配和截断谱合成控制作为两端。理论证明:当秩为满时,该族估计量精确退化为原始路径匹配;在保留K个维度且有N₀个捐赠者时,若N₀ > K+1,则平衡条件欠定,解集为仿射空间,维数为N₀-K-1;谱不平衡通过有限样本最优线性预测分解映射至处理效应偏差。在11种数据生成机制下评估,每种机制重复400次,使用仅捐赠者安慰剂验证选择正则化参数和混合权重。结果表明,截断谱合成控制在所有场景中均显著高于调优后的原始路径匹配,配对差异达4至11个蒙特卡洛标准误。混合估计器多数情况下选择原始路径匹配,在多数场景中与调优的原始路径匹配无统计差异。结果高度依赖预处理:使用原始输入时性能差距大;去除单位与时间固定效应后再做谱分解后,差距几乎消失,安慰剂验证开始倾向截断。结论是诊断性的,而非支持谱合成控制取代原始路径匹配。基估计噪声、平衡欠定性和固定效应污染决定了谱匹配是否有效。

原文摘要 · Abstract (English)

Synthetic control (SC) matches a treated unit's pre-treatment trajectory to a weighted combination of donor units. We study Spectral SC, which instead matches the treated unit in coordinates defined by the leading temporal singular vectors of the donor panel, and a hybrid estimator that places separately tunable weight on retained and discarded directions, nesting raw-path SC and truncated Spectral SC as endpoints. We prove that the family reduces exactly to raw-path SC at full rank, that exact balance on $K$ retained dimensions with $N_0$ donors is underdetermined whenever $N_0>K+1$, with an affine solution set of dimension $N_0-K-1$, and that spectral imbalance maps to treatment-effect bias through a finite-sample best-linear-predictor decomposition. We evaluate the estimators across eleven data-generating regimes, using $400$ replications per regime and donor-only placebo validation to select regularization and the mixing weight. Truncated Spectral SC has significantly higher RMSE than tuned raw-path SC in every regime, with paired differences equal to $4$ to $11$ Monte Carlo standard errors. The hybrid estimator selects raw-path matching in most replications and is statistically indistinguishable from tuned SC in most regimes. The result is highly sensitive to preprocessing. With raw inputs, the performance gap is large; after removing unit and time fixed effects before spectral decomposition, as suggested by the assumptions behind our bound, the gap nearly disappears and placebo validation begins to favor truncation. We interpret these findings diagnostically rather than as evidence that Spectral SC should replace raw-path SC. Basis-estimation noise, balancing underdetermination, and fixed-effects contamination determine when spectral matching can help.

合成控制谱方法因果推断模型比较

Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。